Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
This is an On-demand recording from October 2021
In 2016, the European Commission (EC) released MEDDEV 2.7/1 Revision 4 (MEDDEV) Clinical Evaluation: A Guide for Manufacturers and Notified Bodies Under Directives 93/42/EEC and 90/385/EEC, which was the first indication of sweeping regulatory changes that would occur in Europe affecting medical devices.
This guideline was published and went into immediate effect without a transition period. Manufacturers were still evaluating the changes from the MEDDEV when the EC officially published the EU Medical Device Regulation (MDR) 2017/745 in the Official Journal of the European Union on 05 May 2017. The regulation affirms the expectations of the MEDDEV and expands on the clinical data requirements.
This live broadcast will explain the key changes affecting clinical evaluation, review the phases for clinical evaluation, explain expectations for a systematic literature review, and identify types of clinical data that can be used to support your device.
This event is brought to you by Certara Synchrogenix .
Intermediate: Content is designed based upon the assumption that individuals have basic knowledge of the topic(s) and/or demonstrated competence related to the topic(s). Higher-level concepts are introduced during lectures; exercises requiring synthesis and/or application of concepts are incorporated into the activity.
Attendees will learn to identify:
Angela Siebeneck has more than 30 years of clinical and regulatory experience. She began her career as a registered nurse in a hospital setting and has extensive experience in regulatory strategy, clinical and medical writing. Her experience with regulatory approvals spans Europe, Australia, the US and Asia. Siebeneck has authored or contributed to more than 100 MEDDEV 2.7/1 Rev 4 compliant Clinical Evaluation Reports (CER), as well as postmarket surveillance (PMS) plans/reports, postmarket clinical follow up (PMCF) plans/reports, safety and performance evaluations, human factors studies and regulatory agency responses for medical devices. Her experience encompasses several areas including vascular access, orthopedics, interventional radiology, ophthalmic surgery and surgical instruments.